Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.691.19-0.11-4.0759.14

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 18.69 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.69
Mar20241.19
Mar2023-0.11
Mar2022-4.07
Mar202159.14

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2025 18.69
1,470.59
Mar2024 1.19
Positive
Mar2023 -0.11
Negative
Mar2022 -4.07
Negative
Mar2021 59.14 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹637.1 Cr 0.7% -13.7% 44.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,192.0 Cr 0.3% -4% -6.3% Stock Analytics
DIVIS LABORATORIES ₹161,479.0 Cr 2% -9.6% 33.1% Stock Analytics
CIPLA ₹125,113.0 Cr 1.9% 4.5% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,539.0 Cr 0.6% 3.6% 9.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,926.0 Cr 2% -1% -7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.7%

-13.7%

44.5%

SENSEX

1.3%

-0.8%

3.2%


You may also like the below Video Courses